ABT vs BIO
Abbott Laboratories · Bio-Rad Laboratories Inc
Relative return (rebased to 100)
Key stats
| Metric | ABT | BIO |
|---|---|---|
| Price | $112.47 | $387.70 |
| Market Cap | $195.90B | $10.73B |
| P/E | 30.03 | 14.12 |
| P/B | 3.76 | 1.57 |
| P/S | 4.42 | 4.15 |
| ROE | 12.5% | 11.1% |
| Net Margin | 14.7% | 29.4% |
| Gross Margin | — | 51.9% |
| Revenue Growth | 5.7% | 0.7% |
| Dividend Yield | 2.13% | — |
| EPS | $3.75 | $27.46 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.